|Day's Range||15.69 - 15.81|
|52 Week Range||13.71 - 15.85|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.56%|
Analysts expect Novartis's (NVS) revenues to fall ~1.6% to $12.3 billion in 2Q17 due to the effects of the acquisition and divestiture of some of its products.
Global dividend income ETF GDVD has amassed over $400 million in assets.
Novartis is largely exposed to currency risk, as ~50% of its total revenues are reported from international markets.